India's largest pediatric hospital chain, running children's, maternity & fertility hospitals nationwide.
Price
Market Cap
Sector
Healthcare
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 44 | 44 | 94 | 102 | 102 | 102 | 102 | 102 |
| Reserves | 371 | 421 | 531 | 987 | 1.2k | 1.4k | 1.4k | 1.6k |
| Borrowings | 480 | 495 | 559 | 538 | 735 | 734 | 816 | 801 |
| Other Liabilities | 117 | 109 | 101 | 127 | 130 | 131 | 253 | 158 |
| Total Liabilities | 1.0k | 1.1k | 1.3k | 1.8k | 2.1k | 2.4k | 2.6k | 2.6k |
| AssetsFixed Assets | 663 | 722 | 813 | 891 | 1.2k | 1.4k | 1.6k | 1.5k |
| CWIP | 43 | 29 | 6 | 23 | 20 | 28 | 53 | 79 |
| Investments | 24 | 37 | 42 | 105 | 346 | 596 | 416 | 589 |
| Other Assets | 282 | 282 | 424 | 734 | 566 | 362 | 468 | 522 |
| Total Assets | 1.0k | 1.1k | 1.3k | 1.8k | 2.1k | 2.4k | 2.6k | 2.6k |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 96 | 178 | 142 | 214 | 316 | 306 | 385 | 381 |
| Cash from Investing | -125 | -123 | -87 | -169 | -460 | -214 | -263 | -241 |
| Cash from Financing | 31 | -54 | -56 | -41 | 148 | -97 | -113 | -139 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | 16 | 117 | 66 | 156 | 176 | -46 | 242 | 182 |
| FCF Margin | — | — | — | — | — | — | — | — |
The Earnings Per Share over the last 12 months.
Your assumption of the company's expected yearly EPS growth (e.g., 6 for 6%).
Pre-filled with the lower of median (55.9×) and current (59.8×) PE — the conservative anchor.
The annualized return you aim to achieve. We solve for the price that delivers it, then compare to today's price.
At 5.2% growth and a 56× exit, ₹1471 only delivers your return if you pay ₹747. The price is currently baking in 19% growth.
EPS grows 5.2%/yr for 5 years, then fades to 6% over 2, exits at 56×.
| Year | Growth | EPS (₹) |
|---|---|---|
| FY27 | 5.2% | 25.89 |
| FY28 | 5.2% | 27.24 |
| FY29 | 5.2% | 28.65 |
| FY30 | 5.2% | 30.14 |
| FY31 | 5.2% | 31.71 |
| FY32 | 5.6% ·fade | 33.49 |
| FY33 | 6.0% ·fade | 35.49 |
Methodology: we discount normalized net profit as a proxy for owner earnings (an earnings-power approximation — not full free cash flow). Terminal growth is capped at 6% (≈ nominal GDP) regardless of the required return. This is an analytical tool, not investment advice.
Guides on how to read this kind of business and the numbers that matter.